{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:20:04Z","timestamp":1793920804030,"version":"4.8.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.resinv.2025.04.009","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T02:59:02Z","timestamp":1745290742000},"page":"517-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Macrolide-resistant Mycoplasma pneumoniae infection prevalence increases again in Osaka"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3730-4908","authenticated-orcid":false,"given":"Naoyuki","family":"Miyashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Yamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5419-9156","authenticated-orcid":false,"given":"Tomoki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2025.04.009_bib1","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1128\/AAC.01684-08","article-title":"Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China","volume":"53","author":"Liu","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2025.04.009_bib2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-2334-12-126","article-title":"Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia","volume":"12","author":"Miyashita","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.resinv.2025.04.009_bib3","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3201\/eid2310.170106","article-title":"Macrolide-resistant Mycoplasma pneumoniae infection, Japan, 2008-2015","volume":"23","author":"Tanaka","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2025.04.009_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fcimb.2020.00385","article-title":"Periodic genotype shifts in clinically prevalent Mycoplasma pneumoniae strains in Japan","volume":"10","author":"Kenri","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.resinv.2025.04.009_bib5","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001365","article-title":"P1 gene of Mycoplasma pneumoniae isolated from 2016 to 2019 and relationship between genotyping and macrolide resistance in Hokkaido, Japan","volume":"70","author":"Ishiguro","year":"2021","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.resinv.2025.04.009_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jiac.2020.10.007","article-title":"Recent acute reduction in macrolide-resistant Mycoplasma pneumoniae infections among Japanese children","volume":"27","author":"Nakamura","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2025.04.009_bib7","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/S2666-5247(23)00344-0","article-title":"Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions","volume":"5","author":"Meyer Sauteur","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.resinv.2025.04.009_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1440-1843.2011.02102.x","article-title":"Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"17","author":"Kawai","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2025.04.009_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jgar.2022.01.002","article-title":"Molecular features and antimicrobial susceptibility of Mycoplasma pneumoniae isolates from paediatric inpatients in Weihai, China: characteristics of M. pneumoniae in Weihai","volume":"28","author":"Guo","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.resinv.2025.04.009_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12866-024-03180-0","article-title":"Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020-2022","volume":"24","author":"Xu","year":"2024","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.resinv.2025.04.009_bib11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10156-009-0715-7","article-title":"A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients","volume":"15","author":"Matsubara","year":"2009","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2025.04.009_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1128\/AAC.50.2.709-712.2006","article-title":"Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae","volume":"50","author":"Suzuki","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2025.04.009_bib13","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/AAC.00048-13","article-title":"Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2025.04.009_bib14","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/AAC.00737-13","article-title":"Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility and therapeutic efficacy","volume":"57","author":"Miyashita","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2025.04.009_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jiac.2013.09.009","article-title":"Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature","volume":"20","author":"Izumikawa","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2025.04.009_bib16","series-title":"Guiding principles for treating Mycoplasma pneumoniae pneumonia","first-page":"1","year":"2014"},{"key":"10.1016\/j.resinv.2025.04.009_bib17","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1128\/AAC.00663-13","article-title":"Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2025.04.009_bib18","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.3390\/jcm11071782","article-title":"Recent trends in the epidemiology, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae","volume":"11","author":"Oishi","year":"2022","journal-title":"J Clin Med"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T23:49:59Z","timestamp":1749599399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534525000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2212534525000516"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2025.04.009","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrolide-resistant Mycoplasma pneumoniae infection prevalence increases again in Osaka","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2025.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of The Japanese Respiratory Society.","name":"copyright","label":"Copyright"}]}}